CoChat

Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension

Open access
Zhu, Na, Pauciulo, Michael W., Welch, Carrie L., Lutz, Katie A., Coleman, Anna W., Gonzaga-Jauregui, Claudia, Wang, Jiayao, Grimes, Joseph M., Martin, Lisa J., He, Hua, PAH Biobank Enrolling Centers’ Investigators, Hirsch, Russel, White, R. James, Simon, Marc, Badesch, David, Rosenzweig, Erika, Burger, Charles, Chakinala, Murali, Thenappan, Thenappan, Elliott, Greg, Simms, Robert, Farber, Harrison, Frantz, Robert, Elwing, Jean, Hill, Nicholas, Ivy, Dunbar, Klinger, James, Nathan, Steven, Oudiz, Ronald, Robbins, Ivan, Schilz, Robert, Fortin, Terry, Wilt, Jeffrey, Yung, Delphine, Austin, Eric, Ahmad, Ferhaan, Bhatt, Nitin, Lahm, Tim, Frost, Adaani, Safdar, Zeenat, Rehman, Zia, Walter, Robert, Torres, Fernando, Bakshi, Sahil, Archer, Stephen, Argula, Rahul, Barnett, Christopher, Benza, Raymond, Desai, Ankit, Maddipati, Veeranna, Shen, Yufeng, Chung, Wendy K., Nichols, William C. · 2019 · Genome Medicine
Cited by 135

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Background: Group 1 pulmonary arterial hypertension (PAH) is a rare disease with high mortality despite recent therapeutic advances. Pathogenic remodeling of pulmonary arterioles leads to increased pulmonary pressures, right ventricular hypertrophy, and heart failure. Mutations in bone morphogenetic protein receptor type 2 and other risk genes predispose to disease, but the vast majority of non-familial cases remain genetically undefined. Methods: To identify new risk genes, we performed exome sequencing in a large cohort from the National Biological Sample and Data Repository for PAH (PAH Biobank, n = 2572). We then carried out rare deleterious variant identification followed by case-control gene-based association analyses. To control for population structure, only unrelated European cases ( n = 1832) and controls ( n = 12,771) were used in association tests. Empirical p values were determined by permutation analyses, and the threshold for significance defined by Bonferroni’s correction for multiple testing. Results: Tissue kallikrein 1 ( KLK1 ) and gamma glutamyl carboxylase ( GGCX ) were identified as new candidate risk genes for idiopathic PAH (IPAH) with genome-wide significance. We note that variant carriers had later mean age of onset and relatively moderate disease phenotypes compared to bone morphogenetic receptor type 2 variant carriers. We also confirmed the genome-wide association of recently reported growth differentiation factor ( GDF2 ) with IPAH and further implicate T-box 4 ( TBX4 ) with child-onset PAH. Conclusions: We report robust association of novel genes KLK1 and GGCX with IPAH, accounting for ~ 0.4% and 0.9% of PAH Biobank cases, respectively. Both genes play important roles in vascular hemodynamics and inflammation but have not been implicated in PAH previously. These data suggest new genes, pathogenic mechanisms, and therapeutic targets for this lethal vasculopathy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13073-019-0685-z

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 135

Metadata

Authors
Zhu, N., Pauciulo, M. W., Welch, C. L., Lutz, K. A., Coleman, A. W., Gonzaga-Jauregui, C., Wang, J., Grimes, J. M., Martin, L. J., He, H., PAH Biobank Enrolling Centers’ Investigators, Hirsch, R., White, R. J., Simon, M., Badesch, D., Rosenzweig, E., Burger, C., Chakinala, M., Thenappan, T., Elliott, G., Simms, R., Farber, H., Frantz, R., Elwing, J., Hill, N., Ivy, D., Klinger, J., Nathan, S., Oudiz, R., Robbins, I., Schilz, R., Fortin, T., Wilt, J., Yung, D., Austin, E., Ahmad, F., Bhatt, N., Lahm, T., Frost, A., Safdar, Z., Rehman, Z., Walter, R., Torres, F., Bakshi, S., Archer, S., Argula, R., Barnett, C., Benza, R., Desai, A., Maddipati, V., Shen, Y., Chung, W. K., & Nichols, W. C.
Venue
Genome Medicine
Published
2019-11-14
Volume
11
Issue
1
Pages
69-69
ISSN
1756-994X (ISSN-L)
OpenAlex
W2989484068
Cited by
135
References
9
FWCI
11.53
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension. https://app.cochat.ai/papers/10.1186/s13073-019-0685-z
The paper
Zhu, N., Pauciulo, M. W., Welch, C. L., Lutz, K. A., Coleman, A. W., Gonzaga-Jauregui, C., Wang, J., Grimes, J. M., Martin, L. J., He, H., PAH Biobank Enrolling Centers’ Investigators, Hirsch, R., White, R. J., Simon, M., Badesch, D., Rosenzweig, E., Burger, C., Chakinala, M., Thenappan, T., . . . Nichols, W. C. (2019). Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension. Genome Medicine. https://doi.org/10.1186/s13073-019-0685-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.